|
Indian Journal of Pharmacology
Medknow Publications on behalf of Indian Pharmacological Society
ISSN: 0253-7613 EISSN: 1998-3751
Vol. 36, Num. 2, 2004, pp. 127-127
|
Indian Journal of Pharmacology, Vol. 36, No. 2, April, 2004, pp. 127
Book Review
Book Review
Shewade DG
Department of Pharmacology, JIPMER, Pondicherry - 605006
Correspondence Address:Department of Pharmacology, JIPMER, Pondicherry
- 605006 drshewade@hotmail.com
Code Number: ph04045
Chhattisgarh State Drug Formulary - 2003: Edited by Kaul S, Sunderaraman T, Shastri S and Singh PD. Published by the Department of Health & Family Welfare, Government of Chhattisgarh, Raipur, Pages 381. A drug formulary provides appropriate information about medicines, ensures their proper use and decreases the inappropriate use of medicines. The Health Ministry of the newly carved state of Chhattisgarh has fulfilled its responsibility in this regard. Its Drug Formulary is based on the WHO Model Formulary 2002, by altering the existing text or by aligning the WHO Model Formulary to their list of essential medicines. The changes suit their needs.
While editing the Formulary, medicines used only at the tertiary level
have been deliberately left out indicating that the Formulary is meant
for primary or at the most secondary level of health care. Appendices
covering drug interaction, safety during pregnancy and breast-feeding
have been retained but the effect of renal and hepatic impairment on
drugs has been dropped. However, some useful additional topics like rational
drug therapy, variation in dose response, compliance, adverse drug reaction
(ADR) and prescription writing have been included. The ADR reporting
form should have been included.
The Formulary is of pocket size and hence it is easy to carry. The
format and information provided are appropriate. Certain typographical
errors
have gone unnoticed while proofreading. Further, certain drugs which
are not in common use have been included, e.g. propylthiouracil, salbutamol
injection, and meglumine iotroxate, while certain commonly used drugs
like pentazocine, carbimazole, and parenteral NSAID have been left
out. These defects can be eliminated via effective feedback from the
users.
Cost-effectiveness analysis from time to time can further refine and
improve the next edition of the Formulary.
Standard clinical guidelines for common diseases combined with appropriate
education and training programs aimed at encouraging drug formulary
use are required for rational drug therapy. It is hoped that the
Formulary will be updated at regular intervals and that the state health
care
providers
will adhere to it for its success.
Copyright 2004 - Indian Journal of Pharmacology
|